[{"NetIncomeLoss_1_Q1_USD":-6660000.0,"InventoryFinishedGoodsNetOfReserves_0_Q1_USD":9309000.0,"InterestPaidNet_1_Q1_USD":312000.0,"NetCashProvidedByUsedInInvestingActivities_1_Q1_USD":870000.0,"Depreciation_1_Q1_USD":772000.0,"PaymentsToAcquireInvestments_1_Q1_USD":15279000.0,"AccountsPayableAndAccruedLiabilitiesCurrent_0_Q1_USD":20831000.0,"AssetsCurrent_0_Q1_USD":135145000.0,"LongTermDebt_0_Q1_USD":32140000.0,"FinanceLeaseLiabilityNoncurrent_0_Q1_USD":10000.0,"DerivativeGainLossOnDerivativeNet_1_Q1_USD":-22000.0,"CostOfGoodsAndServicesSold_1_Q1_USD":5172000.0,"SellingAndMarketingExpense_1_Q1_USD":17973000.0,"AccruedSalariesCurrent_0_Q1_USD":6240000.0,"FinanceLeaseInterestExpense_1_Q1_USD":0.0,"OperatingLeaseLeaseIncomeLeasePayments_1_Q1_USD":411000.0,"AccountsReceivableBilledForLongTermContractsOrPrograms_0_Q1_USD":19825000.0,"CommonStockSharesIssued_0_Q1_shares":40842717.0,"InventoryWorkInProcessNetOfReserves_0_Q1_USD":782000.0,"Assets_0_Q1_USD":197369000.0,"UnrealizedGainLossOnInvestments_1_Q1_USD":-15000.0,"ShareBasedCompensation_1_Q1_USD":2694000.0,"OperatingLeaseRightOfUseAsset_0_Q1_USD":15442000.0,"CashUninsuredAmount_0_Q1_USD":39343000.0,"CommonStockParOrStatedValuePerShare_0_Q1_USD":0.01,"IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_1_Q1_USD":313000.0,"CommitmentsAndContingencies_0_Q1_USD":null,"CommonStockSharesAuthorized_0_Q1_shares":100000000.0,"WeightedAverageNumberOfShareOutstandingBasicAndDiluted_1_Q1_shares":40705840.0,"ProvisionForDoubtfulAccounts_1_Q1_USD":-26000.0,"ResearchAndDevelopmentExpense_1_Q1_USD":5748000.0,"FiniteLivedIntangibleAssetsAccumulatedAmortization_0_Q1_USD":931000.0,"InventoryWriteDown_1_Q1_USD":783000.0,"FinanceLeasePrincipalPayments_1_Q1_USD":4000.0,"OtherNonoperatingIncomeExpense_1_Q1_USD":-30000.0,"AccountsReceivableNetCurrent_0_Q1_USD":19825000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_1_Q1_pure":0.5838,"CommonStockValue_0_Q1_USD":408000.0,"Revenues_1_Q1_USD":31037000.0,"InvestmentIncomeNet_1_Q1_USD":34000.0,"IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_1_Q1_USD":-5061000.0,"IntangibleAssetsGrossExcludingGoodwill_0_Q1_USD":3259000.0,"NoncashOrPartNoncashAcquisitionIntangibleAssetsAcquired1_1_Q1_USD":166000.0,"NetCashProvidedByUsedInFinancingActivities_1_Q1_USD":517000.0,"CostsAndExpenses_1_Q1_USD":32085000.0,"DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet_0_Q1_USD":2860000.0,"RestrictedCash_0_Q1_USD":6333000.0,"OtherPrepaidExpenseCurrent_0_Q1_USD":900000.0,"IncreaseDecreaseInInventories_1_Q1_USD":1642000.0,"AmortizationOfIntangibleAssets_1_Q1_USD":47000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_1_Q1_pure":0.0114,"CashAndCashEquivalentsAtCarryingValue_0_Q1_USD":39843000.0,"OperatingLeaseLiabilityNoncurrent_0_Q1_USD":20731000.0,"AdditionalPaidInCapitalCommonStock_0_Q1_USD":329603000.0,"Liabilities_0_Q1_USD":77665000.0,"GeneralAndAdministrativeExpense_1_Q1_USD":8364000.0,"ShortTermInvestments_0_Q1_USD":51062000.0,"OperatingIncomeLoss_1_Q1_USD":-6220000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_1_Q1_pure":0.0,"PaymentsRelatedToTaxWithholdingForShareBasedCompensation_1_Q1_USD":0.0,"AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_1_Q1_USD":2694000.0,"NetCashProvidedByUsedInOperatingActivities_1_Q1_USD":-10820000.0,"InventoryRawMaterialsNetOfReserves_0_Q1_USD":3297000.0,"ProceedsFromSaleOfAvailableForSaleSecuritiesDebt_1_Q1_USD":19400000.0,"LiabilitiesCurrent_0_Q1_USD":22273000.0,"AccountsPayableCurrent_0_Q1_USD":9157000.0,"NonoperatingIncomeExpense_1_Q1_USD":-440000.0,"InterestExpense_1_Q1_USD":444000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_0_Q1_USD":46176000.0,"PrepaidExpenseAndOtherAssetsCurrent_0_Q1_USD":4694000.0,"ProceedsFromStockOptionsExercised_1_Q1_USD":521000.0,"LongTermDebtNoncurrent_0_Q1_USD":32140000.0,"OtherAccruedLiabilitiesCurrent_0_Q1_USD":5434000.0,"IntangibleAssetsNetExcludingGoodwill_0_Q1_USD":2328000.0,"GrossProfit_1_Q1_USD":25865000.0,"FinanceLeaseRightOfUseAssetAmortization_1_Q1_USD":6000.0,"OperatingLeaseWeightedAverageDiscountRatePercent_0_Q1_pure":0.0947,"ShortTermLeaseCost_1_Q1_USD":5000.0,"PaymentsToAcquireIntangibleAssets_1_Q1_USD":156000.0,"FiniteLivedIntangibleAssetsNet_0_Q1_USD":1977000.0,"OperatingLeasePayments_1_Q1_USD":-119000.0,"PrepaidInsurance_0_Q1_USD":2037000.0,"CapitalExpendituresIncurredButNotYetPaid_1_Q1_USD":4836000.0,"PropertyPlantAndEquipmentNet_0_Q1_USD":44395000.0,"FinanceLeaseWeightedAverageDiscountRatePercent_0_Q1_pure":0.0728,"InventoryNet_0_Q1_USD":13388000.0,"AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_0_Q1_USD":5597000.0,"CommonStockSharesOutstanding_0_Q1_shares":40842717.0,"ContractWithCustomerLiabilityCurrent_0_Q1_USD":14000.0,"FiniteLivedIntangibleAssetsGross_0_Q1_USD":2908000.0,"PrepaidAdvertising_0_Q1_USD":580000.0,"OperatingLeaseCost_1_Q1_USD":1047000.0,"LiabilitiesAndStockholdersEquity_0_Q1_USD":197369000.0,"AllocatedShareBasedCompensationExpense_1_Q1_USD":2694000.0,"FinanceLeaseRightOfUseAsset_0_Q1_USD":59000.0,"DerivativeLiabilitiesNoncurrent_0_Q1_USD":2519000.0,"PropertyPlantAndEquipmentGross_0_Q1_USD":49992000.0,"OperatingLeaseLiabilityCurrent_0_Q1_USD":1427000.0,"RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability_1_Q1_USD":321000.0,"EarningsPerShareBasicAndDiluted_1_Q1_USD":-0.16,"OtherLiabilitiesNoncurrent_0_Q1_USD":2000.0,"FinanceLeaseLiabilityCurrent_0_Q1_USD":15000.0,"StockholdersEquity_0_Q1_USD":119704000.0,"InsuranceReceivableForMalpracticeCurrent_0_Q1_USD":23000.0,"ContractWithCustomerLiabilityNoncurrent_0_Q1_USD":2000.0,"PaymentsToAcquirePropertyPlantAndEquipment_1_Q1_USD":3095000.0,"DebtInstrumentCarryingAmount_0_Q1_USD":35000000.0,"AllowanceForDoubtfulAccountsReceivableCurrent_0_Q1_USD":351000.0,"VariableLeaseCost_1_Q1_USD":167000.0,"RetainedEarningsAccumulatedDeficit_0_Q1_USD":-210307000.0,"LeaseCost_1_Q1_USD":1225000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_1_Q1_USD":-9433000.0,"IncreaseDecreaseInAccountsReceivable_1_Q1_USD":2181000.0,"AmortizationOfFinancingCosts_1_Q1_USD":112000.0,"IncreaseDecreaseInContractWithCustomerLiability_1_Q1_USD":-1000.0,"Ticker":"AXGN","CIK":"805928","name":"AXOGEN, INC.","OfficialName":"Axogen Inc. Common Stock","form":"10-Q","period":"20210331","fy":"2021.0","fp":"Q1","qtrs":"1","uom":"USD","footnote":"nan","Market Cap":"313567338.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Electromedical & Electrotherapeutic Apparatus","Market":"NASDAQ","SP500":"nan","filed":"20210506"}]